Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Novartis
Company Monitoring Page for Novartis
latest headlines for company on cafepharma
FDA approves label update of Novartis’ Leqvio to treat high LDL-C
Pharmaceutical Business Review
Tue, 07/11/23 - 10:20 am
Tags:
Novartis
,
Leqvio
,
inclisiran
,
LDL-C
Novartis to appeal district court ruling on heart drug patent
BioPharma Dive
Mon, 07/10/23 - 09:28 pm
Tags:
Novartis
,
Entresto
,
patents
,
legal
Biopharma buyouts bounce back
EP Vantage
Wed, 07/5/23 - 10:17 am
Tags:
M&A
,
Amgen
,
Astellas
,
Eli Lilly
,
GSK
,
Horizon Therapeutics
,
Merck
,
Novartis
,
Pfizer
,
Seagen
Bausch + Lomb to acquire Xiidra, ‘front of eye’ assets from Novartis
Healio
Fri, 06/30/23 - 10:10 am
Tags:
Bausch + Lomb
,
M&A
,
Novartis
,
Xiidra
,
dry eye disease
Ex-Novartis NASH drug clears clinical test, fueling Boston's pursuit of Akero, 89bio
Fierce Biotech
Wed, 06/21/23 - 10:51 am
Tags:
Boston Pharmaceuticals
,
NASH
,
Novartis
,
Akero Therapeutics
,
89Bio
,
BOS-580
CAR-T beyond cancer? Novartis and others say yes
EP Vantage
Mon, 06/19/23 - 10:19 am
Tags:
CAR-T
,
Novartis
,
Cabaletta Bio
,
Cartesian Therapeutics
,
Bristol Myers Squibb
,
Gracell
,
Yake Biotechnology
Sandoz targets barriers to biosimilar accessibility with latest initiative
Pharmaceutical Technology
Thu, 06/15/23 - 07:00 pm
Tags:
Sandoz
,
Novartis
,
patient access
,
biosimilars
Biopharma Confronts a Rising Tide of Ransomware Attacks
BioSpace
Wed, 06/14/23 - 10:11 am
Tags:
cyberattacks
,
cybersecurity
,
ransomware
,
Eisai
,
Sun Pharma
,
Novartis
,
AstraZeneca
,
Merck
Biotech M&A is picking back up - here are the latest deals
BioPharma Dive
Tue, 06/13/23 - 11:37 am
Tags:
Novartis
,
Chinook Therapeutics
,
Paratek
,
Sobi
,
CTI BioPharma
,
Astellas
,
Iveric Bio
,
Assertio Holdings
,
Spectrum Pharmaceuticals
,
Merck
,
Prometheus Biosciences
,
Pfizer
,
Seagen
,
Sanofi
,
Provention Bio
,
Sun Pharma
,
Concert Pharmaceuticals
,
BioNTech
,
InstaDeep
,
AstraXeneca
,
CinCor Pharma
,
Ipsen
,
Albireo
,
Chiesi
,
Amryt
,
Moderna Therapeutics
,
OriCiro Genomics
Hope springs for April inhibition
EP Vantage
Tue, 06/13/23 - 10:27 am
Tags:
Novartis
,
Chinook Therapeutics
,
April inhibition
,
M&A
,
Vera Therapeutics
,
Otsuka
,
RemeGen
,
Alpine Immune Sciences
,
Akso Biopharmaceutical
,
Aurinia Pharmaceuticals
Novartis to acquire kidney disease biotech Chinook for up to $3.5B
BioPharma Dive
Mon, 06/12/23 - 10:24 am
Tags:
Novartis
,
Chinook Therapeutics
,
M&A
,
kidney disease
EHA 2023 – Astrazeneca keeps up its complement defense
EP Vantage
Fri, 06/9/23 - 10:01 am
Tags:
EHA
,
AstraZeneca
,
Alexion
,
Soliris
,
Ultomiris
,
Novartis
,
iptacopan
,
PNH
Novartis debuts hidradenitis suppurativa docuseries at Tribeca Film Festival
Medical Marketing and Media
Thu, 06/8/23 - 09:44 pm
Tags:
Novartis
,
hidradenitis suppurativa
,
documentary
,
pharma marketing
Sandoz hitches its wagon to biosimilars, predicting $3B in sales from pipeline products over next 5 years
Fierce Pharma
Thu, 06/8/23 - 09:29 pm
Tags:
Novartis
,
Sandoz
,
generics
,
biosimilars
ASCO in Review: Oncologists See Practice-Changing, Affirming Data
BioSpace
Thu, 06/8/23 - 09:26 pm
Tags:
ASCO 2023
,
oncologists
,
cancer
,
AstraZeneca
,
Tagrisso
,
non-small cell lung cancer
,
Novartis
,
Kisqali
,
breast cancer
,
Merck
,
Keytruda
,
Moderna Therapeutics
,
cancer vaccine
After Merck's flashpoint IRA lawsuit, Biogen CEO and others register their own complaints
Fierce Biotech
Wed, 06/7/23 - 10:15 am
Tags:
Merck
,
Inflation Reduction Act
,
legal
,
drug pricing
,
Biogen
,
Novartis
,
Genentech
,
BIO 2023
Novartis drug helps stop breast cancer’s return in large study
BioPharma Dive
Fri, 06/2/23 - 11:24 am
Tags:
Novartis
,
Kisqali
,
clinical trials
,
breast cancer
As Sandoz prepares to spin off from Novartis, the company sets sights on new crosstown headquarters
Fierce Pharma
Thu, 06/1/23 - 06:35 pm
Tags:
Novartis
,
biosimilars
,
spinoffs
,
headquarters
Novartis buys priority review voucher from Pharming for discount price of $21M
Fierce Biotech
Thu, 06/1/23 - 11:40 am
Tags:
Novartis
,
Pharming
,
priority review vouchers
ASCO preview: Merck's Keytruda, Novartis' Kisqali face their moment of truth in early-stage cancers
Fierce Pharma
Thu, 05/25/23 - 08:33 pm
Tags:
ASCO 2023
,
Merck
,
Keytruda
,
Novartis
,
Kisqali
,
non-small cell lung cancer
,
early breast cancer
Pages
« first
‹ previous
…
2
3
4
5
6
7
8
9
10
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
An earthquake would most likely shake a: idea, building, breeze
*
Fill in the blank.